Vagus nerve stimulation in ischemic stroke: Old wine in a new bottle

Frontiers in Neurology

Volumn 5 JUN, Issue , 2014, Pages 107-

  Cai, Peter Y ^a,b   Bodhit, Aakash ^a   Derequito, Roselle ^a   Ansari, Saeed ^a,b   Abukhalil, Fawzi ^a   Thenkabail, Spandana ^a   Ganji, Sarah ^a   Saravanapavan, Pradeepan ^a   Shekar, Chandana C ^a   Bidari, Sharatchandra ^b   Waters, Michael F ^a,b   Hedna, Vishnumurthy Shushrutha ^a  

^a UNIVERSITY OF FLORIDA   (United States)

^b UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

Cerebral blood flow; Glutamate excitotoxicity; Middle cerebral artery occlusion; Neuroinflammation; Stroke

Indexed keywords

GLUTAMIC ACID; MELANOCORTIN; NORADRENALIN; REBOXETINE; SEMAPIMOD;

ANTIINFLAMMATORY ACTIVITY; BRADYKINESIA; BRAIN BLOOD FLOW; BRAIN INFARCTION SIZE; BRAIN ISCHEMIA; CEREBROVASCULAR ACCIDENT; EXCITOTOXICITY; HUMAN; MIDDLE CEREBRAL ARTERY OCCLUSION; MUSCLE STRENGTH; NERVOUS SYSTEM INFLAMMATION; NEUROCHEMISTRY; NEUROPROTECTION; NEUROTROPISM; NONHUMAN; OUTCOMES RESEARCH; PATHOPHYSIOLOGY; REVIEW; SOLITARY TRACT NUCLEUS; TREATMENT RESPONSE; VAGUS NERVE; VAGUS NERVE STIMULATION;

EID: 84904437388     PISSN: None     EISSN: 16642295     Source Type: Journal    
DOI: 10.3389/fneur.2014.00107     Document Type: Review

References (58)

1. Bailey P, Bremmer FA. A sensory cortical representation of the vagus nerve with a note on the low pressure on the surface electrogram. J Neurophysiol (1938) 1:404-12.
2. Dell P, Olson R. Thalamic, cortical and cerebellar projections of vagal visceral afferences. C R Seances Soc Biol Fil (1951) 145:1084-8.
3. Zabara J. Inhibition of experimental seizures in canines by repetitive vagal stimulation. Epilepsia (1992) 33(6):1005-12. doi:10.1111/j.1528-1157.1992.tb01751.x
4. Lockard JS, Congdon WC, DuCharme LL. Feasibility and safety of vagal stimulation in monkey model. Epilepsia (1990) 31(Suppl 2):S20-6. doi:10.1111/j.1528-1157.1990.tb05844.x
5. Woodbury DM, Woodbury JW. Effects of vagal stimulation on experimentally induced seizures in rats. Epilepsia (1990) 31(Suppl 2):S7-19. doi:10.1111/j.1528-1157.1990.tb05852.x
6. McLachlan RS. Suppression of interictal spikes and seizures by stimulation of the vagus nerve. Epilepsia (1993) 34(5):918-23. doi:10.1111/j.1528-1157.1993.tb02112.x
7. Penry JK, Dean JC. Prevention of intractable partial seizures by intermittent vagal stimulation in humans: preliminary results. Epilepsia (1990) 31(Suppl 2):S40-3. doi:10.1111/j.1528-1157.1990.tb05848.x
8. O'Reardon JPCP, Peshek AD. Vagus nerve stimulation (VNS) and treatment of depression: to the brainstem and beyond. Psychiatry (Edgmont) (2006) 3(5):54-63.
9. Groves DA, Brown VJ. Vagal nerve stimulation: a review of its applications and potential mechanisms that mediate its clinical effects. Neurosci Biobehav Rev (2005) 29(3):493-500. doi:10.1016/j.neubiorev.2005.01.004
10. Foley JDF. Quantitative studies of the vagus nerve in the cat. I. The ratio of sensory to motor fibers. J Comp Neurol (1937) 67(1):49-67. doi:10.1002/cne.900670104
11. Lulic D, Ahmadian A, Baaj AA, Benbadis SR, Vale FL. Vagus nerve stimulation. Neurosurg Focus (2009) 27(3):E5. doi:10.3171/2009.6.FOCUS09126
12. Ansari S, Chaudhri K, Al Moutaery KA. Vagus nerve stimulation: indications and limitations. Acta Neurochir Suppl (2007) 97(Pt 2):281-6. doi:10.1007/978-3-211-33081-4_31
13. Henry TR. Therapeutic mechanisms of vagus nerve stimulation. Neurology (2002) 59(6 Suppl 4):S3-14. doi:10.1212/WNL.59.6_suppl_4.S3
14. Mu Q, Bohning DE, Nahas Z, Walker J, Anderson B, Johnson KA, et al. Acute vagus nerve stimulation using different pulse widths produces varying brain effects. Biol Psychiatry (2004) 55(8):816-25. doi:10.1016/j.biopsych.2003.12.004
15. Cheyuo C, Jacob A, Wu R, Zhou M, Coppa GF, Wang P. The parasympathetic nervous system in the quest for stroke therapeutics. J Cereb Blood Flow Metab (2011) 31(5):1187-95. doi:10.1038/jcbfm.2011.24
16. Morris GL III, Gloss D, Buchhalter J, Mack KJ, Nickels K, Harden C. Evidence-based guideline update: vagus nerve stimulation for the treatment of epilepsy: report of the guideline development subcommittee of the American Academy of Neurology. Epilepsy Curr (2013) 13(6):297-303. doi:10.5698/1535-7597-13.6.297
17. McGregor A, Wheless J, Baumgartner J, Bettis D. Right-sided vagus nerve stimulation as a treatment for refractory epilepsy in humans. Epilepsia (2005) 46(1):91-6. doi:10.1111/j.1528-1167.2005.09205_2.x
18. Ben-Menachem E. Vagus nerve stimulation, side effects, and long-term safety. J Clin Neurophysiol (2001) 18(5):415-8. doi:10.1097/00004691-200109000-00005
19. Roger VL, Go AS, Lloyd-Jones DM, Benjamin EJ, Berry JD, Borden WB, et al. Heart disease and stroke statistics - 2012 update: a report from the American Heart Association. Circulation (2012) 125(1):e2-220. doi:10.1161/CIR.0b013e31823ac046
20. Chavez JC, Hurko O, Barone FC, Feuerstein GZ. Pharmacologic interventions for stroke: looking beyond the thrombolysis time window into the penumbra with biomarkers, not a stopwatch. Stroke (2009) 40(10):e558-63. doi:10.1161/STROKEAHA.109.559914
21. Yenari MA, Han HS. Neuroprotective mechanisms of hypothermia in brain ischaemia. Nat Rev Neurosci (2012) 13(4):267-78. doi:10.1038/nrn3174
22. Ay I, Lu J, Ay H, Gregory Sorensen A. Vagus nerve stimulation reduces infarct size in rat focal cerebral ischemia. Neurosci Lett (2009) 459(3):147-51. doi:10.1016/j.neulet.2009.05.018
23. Ay I, Sorensen AG, Ay H. Vagus nerve stimulation reduces infarct size in rat focal cerebral ischemia: an unlikely role for cerebral blood flow. Brain Res (2011) 1392:110-5. doi:10.1016/j.brainres.2011.03.060
24. Hiraki T, Baker W, Greenberg JH. Effect of vagus nerve stimulation during transient focal cerebral ischemia on chronic outcome in rats. J Neurosci Res (2012) 90(4):887-94. doi:10.1002/jnr.22812
25. Sun Z, Baker W, Hiraki T, Greenberg JH. The effect of right vagus nerve stimulation on focal cerebral ischemia: an experimental study in the rat. Brain Stimul (2012) 5(1):1-10. doi:10.1016/j.brs.2011.01.009
26. Ay I, Ay H. Ablation of the sphenopalatine ganglion does not attenuate the infarct reducing effect of vagus nerve stimulation. Auton Neurosci (2013) 174(1-2):31-5. doi:10.1016/j.autneu.2012.12.001
27. Khodaparast N, Hays SA, Sloan AM, Hulsey DR, Ruiz A, Pantoja M, et al. Vagus nerve stimulation during rehabilitative training improves forelimb strength following ischemic stroke. Neurobiol Dis (2013) 60:80-8. doi:10.1016/j.nbd.2013.08.002
28. Khodaparast N, Hays SA, Sloan AM, Fayyaz T, Hulsey DR, Rennaker RL II, et al. Vagus nerve stimulation delivered during motor rehabilitation improves recovery in a rat model of stroke. Neurorehabil Neural Repair (2014). doi:10.1177/1545968314521006
29. Lin TN, He YY, Wu G, Khan M, Hsu CY. Effect of brain edema on infarct volume in a focal cerebral ischemia model in rats. Stroke (1993) 24(1):117-21. doi:10.1161/01.STR.24.1.117
30. Okuno S, Nakase H, Sakaki T. Comparative study of 2,3,5-triphenyltetrazolium chloride (TTC) and hematoxylin-eosin staining for quantification of early brain ischemic injury in cats. Neurol Res (2001) 23(6):657-61. doi:10.1179/016164101101198983
31. Clough RW, Neese SL, Sherill LK, Tan AA, Duke A, Roosevelt RW, et al. Cortical edema in moderate fluid percussion brain injury is attenuated by vagus nerve stimulation. Neuroscience (2007) 147(2):286-93. doi:10.1016/j.neuroscience.2007.04.043
32. Conway CR, Sheline YI, Chibnall JT, Bucholz RD, Price JL, Gangwani S, et al. Brain blood-flow change with acute vagus nerve stimulation in treatment-refractory major depressive disorder. Brain Stimul (2012) 5(2):163-71. doi:10.1016/j.brs.2011.03.001
33. Mravec B. The role of the vagus nerve in stroke. Auton Neurosci (2010) 158(1-2):8-12. doi:10.1016/j.autneu.2010.08.009
34. Ottani A, Giuliani D, Mioni C, Galantucci M, Minutoli L, Bitto A, et al. Vagus nerve mediates the protective effects of melanocortins against cerebral and systemic damage after ischemic stroke. J Cereb Blood Flow Metab (2009) 29(3):512-23. doi:10.1038/jcbfm.2008.140
35. Borovikova LV, Ivanova S, Zhang M, Yang H, Botchkina GI, Watkins LR, et al. Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin. Nature (2000) 405(6785):458-62. doi:10.1038/35013070
36. Miyamoto O, Pang J, Sumitani K, Negi T, Hayashida Y, Itano T. Mechanisms of the anti-ischemic effect of vagus nerve stimulation in the gerbil hippocampus. Neuroreport (2003) 14(15):1971-4. doi:10.1097/00001756-200310270-00018
37. Walker BR, Easton A, Gale K. Regulation of limbic motor seizures by GABA and glutamate transmission in nucleus tractus solitarius. Epilepsia (1999) 40(8):1051-7. doi:10.1111/j.1528-1157.1999.tb00818.x
38. Ben-Menachem E, Hamberger A, Hedner T, Hammond EJ, Uthman BM, Slater J, et al. Effects of vagus nerve stimulation on amino acids and other metabolites in the CSF of patients with partial seizures. Epilepsy Res (1995) 20(3):221-7. doi:10.1016/0920-1211(94)00083-9
39. Roosevelt RW, Smith DC, Clough RW, Jensen RA, Browning RA. Increased extracellular concentrations of norepinephrine in cortex and hippocampus following vagus nerve stimulation in the rat. Brain Res (2006) 1119(1):124-32. doi:10.1016/j.brainres.2006.08.048
40. Duman RS, Heninger GR, Nestler EJ. A molecular and cellular theory of depression. Arch Gen Psychiatry (1997) 54(7):597-606. doi:10.1001/archpsyc.1997.01830190015002
41. Follesa P, Biggio F, Gorini G, Caria S, Talani G, Dazzi L, et al. Vagus nerve stimulation increases norepinephrine concentration and the gene expression of BDNF and bFGF in the rat brain. Brain Res (2007) 1179:28-34. doi:10.1016/j.brainres.2007.08.045
42. Sattler R, Tymianski M. Molecular mechanisms of glutamate receptor-mediated excitotoxic neuronal cell death. Mol Neurobiol (2001) 24(1-3):107-29. doi:10.1385/MN:24:1-3:107
43. Dello Russo C, Boullerne AI, Gavrilyuk V, Feinstein DL. Inhibition of microglial inflammatory responses by norepinephrine: effects on nitric oxide and interleukin-1beta production. J Neuroinflammation (2004) 1(1):9. doi:10.1186/1742-2094-1-9
44. O'Sullivan JB, Ryan KM, Harkin A, Connor TJ. Noradrenaline reuptake inhibitors inhibit expression of chemokines IP-10 and RANTES and cell adhesion molecules VCAM-1 and ICAM-1 in the CNS following a systemic inflammatory challenge. J Neuroimmunol (2010) 220(1-2):34-42. doi:10.1016/j.jneuroim.2009.12.007
45. Liepert J. Pharmacotherapy in restorative neurology. Curr Opin Neurol (2008) 21(6):639-43. doi:10.1097/WCO.0b013e32831897a3
46. Shytle RD, Mori T, Townsend K, Vendrame M, Sun N, Zeng J, et al. Cholinergic modulation of microglial activation by alpha 7 nicotinic receptors. J Neurochem (2004) 89(2):337-43. doi:10.1046/j.1471-4159.2004.02347.x
47. Parada E, Egea J, Romero A, del Barrio L, Garcia AG, Lopez MG. Poststress treatment with PNU282987 can rescue SH-SY5Y cells undergoing apoptosis via alpha7 nicotinic receptors linked to a Jak2/Akt/HO-1 signaling pathway. Free Radic Biol Med (2010) 49(11):1815-21. doi:10.1016/j.freeradbiomed.2010.09.017
48. Blalock JE. Harnessing a neural-immune circuit to control inflammation and shock. J Exp Med (2002) 195(6):F25-8. doi:10.1084/jem.20020602
49. Kreuzer PM, Landgrebe M, Husser O, Resch M, Schecklmann M, Geisreiter F, et al. Transcutaneous vagus nerve stimulation: retrospective assessment of cardiac safety in a pilot study. Front Psychiatry (2012) 3:70. doi:10.3389/fpsyt.2012.00070
50. Stefan H, Kreiselmeyer G, Kerling F, Kurzbuch K, Rauch C, Heers M, et al. Transcutaneous vagus nerve stimulation (t-VNS) in pharmacoresistant epilepsies: a proof of concept trial. Epilepsia (2012) 53(7):e115-8. doi:10.1111/j.1528-1167.2012.03492.x
51. He W, Jing XH, Zhu B, Zhu XL, Li L, Bai WZ, et al. The auriculo-vagal afferent pathway and its role in seizure suppression in rats. BMC Neurosci (2013) 14:85. doi:10.1186/1471-2202-14-85
52. He W, Jing X, Wang X, Rong P, Li L, Shi H, et al. Transcutaneous auricular vagus nerve stimulation as a complementary therapy for pediatric epilepsy: a pilot trial. Epilepsy Behav (2013) 28(3):343-6.
53. Busch V, Zeman F, Heckel A, Menne F, Ellrich J, Eichhammer P. The effect of transcutaneous vagus nerve stimulation on pain perception - an experimental study. Brain Stimul (2013) 6(2):202-9.
54. Macrae IM. Preclinical stroke research - advantages and disadvantages of the most common rodent models of focal ischaemia. Br J Pharmacol (2011) 164(4):1062-78.
55. Howells DW, Porritt MJ, Rewell SS, O'Collins V, Sena ES, van der Worp HB, et al. Different strokes for different folks: the rich diversity of animal models of focal cerebral ischemia. J Cereb Blood Flow Metab (2010) 30(8):1412-31.
56. Casals JB, Pieri NC, Feitosa ML, Ercolin AC, Roballo KC, Barreto RS, et al. The use of animal models for stroke research: a review. Comp Med (2011) 61(4):305-13.
57. Fisher M, Feuerstein G, Howells DW, Hurn PD, Kent TA, Savitz SI, et al. Update of the stroke therapy academic industry roundtable preclinical recommendations. Stroke (2009) 40(6):2244-50.
58. Hossmann KA. The two pathophysiologies of focal brain ischemia: implications for translational stroke research. J Cereb Blood Flow Metab (2012) 32(7):1310-6. doi:10.1038/jcbfm.2011.186